Multiomic Health

General Information

Company Name

Multiomic Health

Founded Year

2021

Location (Offices)

London, United Kingdom +1

Founders / Decision Makers

Number of Employees

Industries

AI, Biotechnology, Health Care +2

Funding Stage

Seed

Social Media

Multiomic Health - Company Profile

Multiomic Health is a data-centric therapeutics venture focusing on precision medicine for metabolic syndrome-related conditions such as atherosclerotic cardiovascular disease, type 2 diabetes, chronic kidney disease, and non-alcoholic fatty liver. Founded in 2021 and headquartered in the United Kingdom, the company is on a mission to revolutionize patient health outcomes through advanced computational systems biology modeling and AI-enabled predictive analytics. Multiomic Health leverages deep, standardized patient datasets with millions of data points per patient to identify unique patient endotypes and develop breakthrough precision therapeutics.

With a slogan of "AI-Enabled Precision Medicine for Metabolic Syndrome-Related Conditions," Multiomic Health has recently secured a significant $6.20M in seed round investment on 04 May 2023. The investment was led by MMC Ventures, Ada Ventures, Hoxton Ventures, Verve Ventures, and Selvedge Venture, showcasing strong support from prominent venture capital firms.

By addressing a global trillion-dollar healthcare problem, Multiomic Health is positioned at the intersection of AI, Biotechnology, Health Care, Health and Wellness, and Life Sciences industries, demonstrating its potential for impactful innovation and growth in the healthcare sector.

Taxonomy: Precision Medicine, AI-enabled Therapeutics, Metabolic Syndrome, Multiomic Health, Data-Centric Venture, Predictive Analytics, Computational Systems Biology, Data Modeling, Drug Discovery, Therapeutics, AI in Healthcare, Patient Datasets, Precision Therapeutics, Predictive Modeling, Healthcare Innovation